Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 0378-5440

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate (NDC 0378-5440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Emtricitabine Structural Formula (Image 01)

FDA Label Image

Rilpivirine Hydrochloride Structural Formula (Image 02)

FDA Label Image

Tdf Structural Formula (Image 03)

FDA Label Image

Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate Tablets Carton Label (Image 04)

This text provides information about a medication containing Emtricitabine, Rilpivirine, and Tenofovir Disoproxil, at specific dosages. The dosage form is in tablets (200 mg/25 mg/300 mg). It mentions keeping the medication out of reach, dispensing in the original container, and cautions against alcohol use. The medication is manufactured by a company named Topharmazit and Mylan®. The text also includes references to lot number, expiration date, and variable data coding.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.